Evaluation of Vitek MS for Differentiation of Cryptococcus neoformans and Cryptococcus gattii Genotypes

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorSIQUEIRA, Lumena P. Machado
dc.contributor.authorGIMENES, Viviane M. Favero
dc.contributor.authorFREITAS, Roseli Santos de
dc.contributor.authorMELHEM, Marcia de Souza Carvalho
dc.contributor.authorBONFIETTI, Lucas Xavier
dc.contributor.authorJR, Afonso Rafael da Silva
dc.contributor.authorSANTOS, Leticia B. Souza
dc.contributor.authorMOTTA, Adriana L.
dc.contributor.authorROSSI, Flavia
dc.contributor.authorBENARD, Gil
dc.contributor.authorJR, Joao N. de Almeida
dc.date.accessioned2019-02-21T17:23:46Z
dc.date.available2019-02-21T17:23:46Z
dc.date.issued2019
dc.description.abstractCryptococcus neoformans and Cryptococcus gattii are the main pathogenic species of invasive cryptococcosis among the Cryptococcus species. Taxonomic studies have shown that these two taxa have different genotypes or molecular types with biological and ecoepidemiological peculiarities. Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has been proposed as an alternative method for labor-intensive methods for C. neoformans and C. gattii genotype differentiation. However, Vitek MS, one of the commercial MALDI-TOF MS instruments, has not been yet been evaluated for this purpose. Thus, we constructed an in-house database with reference strains belonging to the different C. neoformans (VNI, VNII, VNIII, and VNIV) and C. gattii (VGI, VGII, VGIII, and VGIV) major molecular types by using the software Saramis Premium (bioMerieux, Marcy-l'Etoile, France). Then, this new database was evaluated for discrimination of the different genotypes. Our in-house database provided correct identification for all C. neoformans and C. gattii genotypes; however, due to the intergenotypic mass spectral similarities, a careful postanalytic evaluation is necessary to provide correct genotype identification.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipNational Council of Technological and Scientific Development [CNPQ 421374/2016-0]
dc.identifier.citationJOURNAL OF CLINICAL MICROBIOLOGY, v.57, n.1, article ID UNSP e01282, 7p, 2019
dc.identifier.doi10.1128/JCM.01282-18
dc.identifier.eissn1098-660X
dc.identifier.issn0095-1137
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/30836
dc.language.isoeng
dc.publisherAMER SOC MICROBIOLOGYeng
dc.relation.ispartofJournal of Clinical Microbiology
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright AMER SOC MICROBIOLOGYeng
dc.subjectCryptococcus gattiieng
dc.subjectCryptococcus neoformanseng
dc.subjectMALDI-TOFeng
dc.subjectVITEK MSeng
dc.subjectgenotypic identificationeng
dc.subject.otherdesorption ionization-timeeng
dc.subject.otherflight mass-spectrometryeng
dc.subject.othermolecular typeseng
dc.subject.otheridentificationeng
dc.subject.othercomplexeng
dc.subject.otherivdeng
dc.subject.wosMicrobiologyeng
dc.titleEvaluation of Vitek MS for Differentiation of Cryptococcus neoformans and Cryptococcus gattii Genotypeseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.author.externalMELHEM, Marcia de Souza Carvalho:Adolfo Lutz Inst, Secao Micol, Div Tecn Biol Med, Sao Paulo, Brazil
hcfmusp.author.externalBONFIETTI, Lucas Xavier:Adolfo Lutz Inst, Secao Micol, Div Tecn Biol Med, Sao Paulo, Brazil
hcfmusp.citation.scopus12
hcfmusp.contributor.author-fmusphcLUMENA PEREIRA MACHADO SIQUEIRA
hcfmusp.contributor.author-fmusphcVIVIANE MAZO FAVERO GIMENES
hcfmusp.contributor.author-fmusphcROSELI SANTOS DE FREITAS
hcfmusp.contributor.author-fmusphcAFONSO RAFAEL DA SILVA JUNIOR
hcfmusp.contributor.author-fmusphcLETICIA BONATO SOUZA SANTOS
hcfmusp.contributor.author-fmusphcADRIANA LOPES MOTTA
hcfmusp.contributor.author-fmusphcFLAVIA ROSSI
hcfmusp.contributor.author-fmusphcGIL BENARD
hcfmusp.contributor.author-fmusphcJOAO NOBREGA DE ALMEIDA JUNIOR
hcfmusp.description.articlenumberUNSP e01282
hcfmusp.description.issue1
hcfmusp.description.volume57
hcfmusp.origemWOS
hcfmusp.origem.pubmed30429250
hcfmusp.origem.scopus2-s2.0-85059373523
hcfmusp.origem.wosWOS:000455018000014
hcfmusp.publisher.cityWASHINGTONeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceCHANG YC, 1994, MOL CELL BIOL, V14, P4912, DOI 10.1128/MCB.14.7.4912eng
hcfmusp.relation.referenceChen SCA, 2014, CLIN MICROBIOL REV, V27, P980, DOI 10.1128/CMR.00126-13eng
hcfmusp.relation.referencede Almeida JN, 2017, J CLIN MICROBIOL, V55, P2439, DOI 10.1128/JCM.00461-17eng
hcfmusp.relation.referenceDel Poeta M, 2012, MYCOPATHOLOGIA, V173, P303, DOI 10.1007/s11046-011-9473-zeng
hcfmusp.relation.referenceEspinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P5898, DOI 10.1128/AAC.01115-12eng
hcfmusp.relation.referenceFiracative C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037566eng
hcfmusp.relation.referenceGrenfell RC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00940eng
hcfmusp.relation.referenceHagen F, 2011, MYCOSES, V54, P78eng
hcfmusp.relation.referenceHagen F, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00238-17eng
hcfmusp.relation.referenceHagen F, 2015, FUNGAL GENET BIOL, V78, P16, DOI 10.1016/j.fgb.2015.02.009eng
hcfmusp.relation.referenceHibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004eng
hcfmusp.relation.referenceHittinger CT, 2015, CURR OPIN GENET DEV, V35, P100, DOI 10.1016/j.gde.2015.10.008eng
hcfmusp.relation.referenceKidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101eng
hcfmusp.relation.referenceLacaz CS, 2002, TRATADO MICOLOGIA MEeng
hcfmusp.relation.referenceLeyer C, 2017, J CLIN MICROBIOL, V55, P2045, DOI [10.1128/jcm.00006-17, 10.1128/JCM.00006-17]eng
hcfmusp.relation.referenceMeyer W, 2003, EMERG INFECT DIS, V9, P189eng
hcfmusp.relation.referenceNormand AC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-76eng
hcfmusp.relation.referencePappalardo Mara C.S.M., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P299, DOI 10.1590/S0036-46652003000600001eng
hcfmusp.relation.referencePosteraro B, 2012, J CLIN MICROBIOL, V50, P2472, DOI 10.1128/JCM.00737-12eng
hcfmusp.relation.referenceRychert J, 2013, J CLIN MICROBIOL, V51, P2225, DOI 10.1128/JCM.00682-13eng
hcfmusp.relation.referenceSevero CB, 2009, PAEDIATR RESPIR REV, V10, P166, DOI 10.1016/j.prrv.2009.06.009eng
hcfmusp.relation.referenceTrilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008eng
hcfmusp.relation.referenceWelker M, 2011, PROTEOMICS, V11, P3143, DOI 10.1002/pmic.201100049eng
hcfmusp.relation.referenceZhou LR, 2017, INFECT DRUG RESIST, V10, P499, DOI 10.2147/IDR.S148121eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublicationc36f4833-bd3c-4317-9a45-f9d39c6ade61
relation.isAuthorOfPublication85d5eb8a-3696-403a-bca4-94122dd7cd7c
relation.isAuthorOfPublication14a8e51f-1be5-4d56-9e9e-63e6ebd87e9a
relation.isAuthorOfPublication03a27105-36af-431d-9501-4863f08e027b
relation.isAuthorOfPublicationbb564a20-9cbf-4624-a947-0822b7d195a7
relation.isAuthorOfPublication127befd9-b751-40e1-bf68-bdd4bd3b9011
relation.isAuthorOfPublicationc23ed5c0-298e-4bc7-acfb-bcaa7ed9ea93
relation.isAuthorOfPublication435ea94f-594d-4595-b5f5-1df649516e3c
relation.isAuthorOfPublication238dc791-e192-4ac8-9bdd-693de40b32cf
relation.isAuthorOfPublication.latestForDiscoveryc36f4833-bd3c-4317-9a45-f9d39c6ade61
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_SIQUEIRA_Evaluation_of_Vitek_MS_for_Differentiation_of_Cryptococcus_2019.PDF
Tamanho:
1.44 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)